Gianluca Pettiti, the President and Chief Operating Officer of Thermo Fisher Scientific Inc., has disclosed several stock transactions in a recent SEC filing. This report, filed on November 16, 2026, outlines multiple transactions that include both sales and acquisitions of common stock. The activity is significant as it reflects the executive's ongoing investment strategies and may influence perceptions of the company's market position.

Background

Thermo Fisher Scientific Inc. operates within the measuring and controlling devices sector, specifically categorized under the Standard Industrial Classification (SIC) code 3829. The company is known for its advanced technologies and services that support scientific research and healthcare. The recent filing comes as part of a series of disclosures from Pettiti, with previous filings dating back to April 2026.

What the Filing Says

The SEC filing, accession number 0000097745-26-000184, details several transactions that Pettiti executed on November 13, 2026. Notably, he sold 400 shares of common stock at a price of $701.42 per share and acquired 3,733 shares at a price of $309.63 per share. Additionally, he exercised stock options for another 3,733 shares, which were set to expire on February 25, 2027.

Impact

The reported transactions may affect stakeholders, including shareholders and potential investors, by providing insights into the executive's confidence in the company's future performance. Pettiti's actions could be indicative of broader trends in executive compensation and stock management within the measuring and controlling devices industry.

What's Next

The filing does not specify what happens next regarding Pettiti's investment strategy or any upcoming corporate actions.